3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?
ACS Materials Au · 08.11.2023 · 3 (6) · 620-635
DOI: 10.1021/acsmaterialsau.3c00046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Materials Au, online erschienen am 28.08.2023. Verfasst von Yu Zhang. Beteiligte Einrichtung: Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78705, United States. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78705, United States.
- Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, Oxford, Mississippi 38677-1848, United States.
ORCID-Profile: Yu Zhang
Zitieren
APA
Zhang, Y. (2023). 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?. ACS Materials Au, 3(6), 620-635. https://doi.org/10.1021/acsmaterialsau.3c00046
Vancouver
Zhang Y. 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?. ACS Materials Au. 2023;3(6):620-635. doi:10.1021/acsmaterialsau.3c00046
BibTeX
@article{Zhang2023,
author = {Zhang, Yu},
title = {3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?},
journal = {ACS Materials Au},
year = {2023},
volume = {3},
number = {6},
pages = {620--635},
doi = {10.1021/acsmaterialsau.3c00046}
}
EUVIMED